Oral Thin Films Market Size, Share, Growth Analysis, By Type(Sublingual Film, Fully Dissolving Dental/Buccal Film), By Application(Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2121 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 64 |Figures: 75

Oral Thin Films Market Insights

Oral Thin Films Market size was valued at USD 3.17 Billion in 2022 and is poised to grow from USD 3.46 Billion in 2023 to USD 7.05 Billion by 2031, at a CAGR of 9.3% during the forecast period (2024-2031).

The global oral thin films market refers to the industry involved in the production and distribution of thin, dissolvable strips used for drug delivery through oral absorption. The purpose of the global oral thin films market is to provide a convenient and patient-friendly alternative to traditional oral dosage forms like tablets and capsules. Oral thin films offer advantages such as ease of administration, accurate dosage, rapid disintegration, and potentially improved patient compliance. They are used to deliver a wide range of pharmaceutical compounds, including prescription drugs, over-the-counter medications, and nutraceuticals.

A driving factor for the global oral thin films market is the increasing demand for innovative drug delivery systems that enhance patient experience and adherence to medication regimens. Oral thin films provide a non-invasive and user-friendly method of drug administration, particularly suitable for pediatric and geriatric populations. The ease of use and potential for taste masking also make oral thin films attractive for patients who have difficulty swallowing traditional tablets or capsules. However, there are restraining factors and challenges that impact the market. One key restraining factor is the complex and costly manufacturing process associated with oral thin films. Developing and scaling up the production of these specialized dosage forms requires advanced equipment and expertise, which can limit the availability and affordability of oral thin films. Additionally, regulatory requirements and intellectual property concerns pose challenges to market entry and growth. Furthermore, competition from alternative drug delivery methods and established oral dosage forms is another challenge in the market.

Traditional tablets and capsules continue to dominate the pharmaceutical market, and other innovative drug delivery systems, such as transdermal patches and inhalation devices, compete for market share. Overcoming the perception barriers and establishing the efficacy and safety of oral thin films compared to these established options can be challenging. Despite these challenges, there are significant opportunities in the global oral thin films market. The growing demand for personalized medicine, pediatric medications, and self-administered therapies opens doors for innovative drug delivery systems like oral thin films. Additionally, expanding applications in the nutraceutical and over-the-counter sectors present avenues for market growth.

US Oral Thin Films Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 2.90 Billion

Largest Segment

Sublingual Film

Fastest Growth

Sublingual Film

Growth Rate

9.3% CAGR

Global Oral Thin Films Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Oral Thin Films Market Segmental Analysis

The global oral thin films market is segmented on the basis of type, application, and region. By type, the market is segmented into Sublingual Film, and Fully Dissolving Dental/Buccal Film. By Application, the market is segmented into Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Oral Thin Films Market Analysis by Type

The largest segment in the global oral thin films market is the sublingual film segment, accounting for the majority of the market share. Sublingual films are placed under the tongue and dissolve quickly, allowing for rapid drug absorption into the bloodstream. This segment is popular due to the ease of use, as sublingual films do not require water or swallowing, making them an attractive option for patients who have difficulty swallowing pills or capsules. Additionally, sublingual films can provide a more consistent dose of medication compared to other oral dosage forms.

The fastest-growing segment in the global oral thin films market is the fully dissolving dental/buccal film segment. These films are placed on the inside of the cheek or on the gums and dissolve quickly, allowing for fast drug absorption. The growing demand for dental/buccal films is due to their ease of use and convenience, making them an attractive option for patients who require medication while on-the-go. Additionally, dental/buccal films have a longer shelf life compared to other oral dosage forms, making them a preferred option for pharmaceutical manufacturers.

Oral Thin Films Market Analysis by Process

Schizophrenia represents the largest segment in the global oral thin films market. Oral thin films offer an effective and convenient method of delivering medications for individuals diagnosed with schizophrenia. These films can be formulated with antipsychotic medications, allowing for precise dosing and rapid drug absorption. The use of oral thin films in schizophrenia treatment helps improve patient compliance, ensuring consistent medication intake. With a significant global prevalence of schizophrenia, the demand for oral thin films in this application is substantial. The advantages of targeted drug delivery and enhanced patient experience position the schizophrenia segment as the largest within the global market.

The fastest-growing segment in the global oral thin films market is migraine treatment. Migraine is a prevalent neurological condition affecting millions of individuals worldwide. Oral thin films provide a promising solution for delivering migraine medications, allowing for rapid onset of action and relief. The convenience of oral thin films makes them appealing to individuals experiencing migraines, as they offer a non-invasive and easily-administered alternative to traditional oral tablets. The growing awareness about migraine management, along with the increasing demand for personalized and patient-centric treatment options, drives the rapid growth of oral thin films in the migraine segment. As more healthcare providers and patients recognize the benefits of targeted drug delivery and improved patient experience, the market share of oral thin films in migraine treatment is projected to expand significantly.

Global Oral Thin Films Market By Type

To get detailed analysis on other segments, Request For Free Sample Report

Oral Thin Films Market Regional Insights

North America emerges as the dominating region in the global oral thin films market. This region is characterized by advanced healthcare infrastructure, a strong pharmaceutical industry, and a high prevalence of various diseases requiring oral medication. The United States, in particular, contributes significantly to the market due to its robust healthcare system, increasing adoption of innovative drug delivery systems, and a large patient population. Moreover, North America is home to several key players in the oral thin films market, driving the dominance of this region.

Asia Pacific showcases the fastest-growing region in the global oral thin films market. The region's growing population, improving healthcare infrastructure, and rising awareness of personalized medicine contribute to the increasing demand for oral thin films. Countries such as China, India, Japan, and South Korea are witnessing significant growth in the pharmaceutical sector and are becoming key markets for oral thin films. The region's expanding middle class, coupled with the increasing prevalence of chronic diseases, drives the adoption of oral thin films as a convenient and patient-friendly drug delivery option. Furthermore, favorable government initiatives, increasing investments in healthcare, and the presence of contract manufacturing organizations supporting the production of oral thin films contribute to the region's rapid growth.

Global Oral Thin Films Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Oral Thin Films Market Dynamics

Oral Thin Films Market Drivers

Increasing Patient Preference for Non-Invasive Drug Delivery

  • One of the key drivers in 2022 was the growing patient preference for non-invasive drug delivery methods. Oral thin films offer a convenient and patient-friendly alternative to traditional oral dosage forms like tablets and injections. Patients appreciate the ease of administration, rapid disintegration, and potentially improved medication compliance provided by oral thin films. This driver was further reinforced by the ongoing COVID-19 pandemic, where non-invasive drug delivery methods gained more prominence due to safety concerns.

Rise in Chronic Diseases and Disorders

  • The increasing prevalence of chronic diseases and disorders acted as a driver for the oral thin films market. Conditions such as schizophrenia, migraine, and opioid dependence require long-term medication regimens. Oral thin films offer a suitable drug delivery platform for managing these chronic conditions as they provide accurate dosing, targeted drug delivery, and potential improved patient adherence. The rising global burden of chronic diseases contributed to the demand for oral thin films as an effective treatment option.

Oral Thin Films Market Restraints

Complex Manufacturing Processes

  • A significant restraint in the oral thin films market in 2022 was the complex manufacturing processes associated with these specialized dosage forms. Developing and scaling up the production of oral thin films require advanced equipment, expertise, and stringent quality control. The complexity of manufacturing and associated costs can limit the availability and affordability of oral thin films, hindering market growth.

Intellectual Property Concerns

  • Intellectual property concerns presented another restraint in the oral thin films market. Innovators and manufacturers in this sector face challenges related to patent protection, preventing potential imitation and infringement. Intellectual property concerns can impact market entry and the ability of companies to recoup investments in research and development, thereby affecting market growth and innovation.

Request Free Customization of this report to help us to meet your business objectives.

Oral Thin Films Market Competitive Landscape

The global oral thin films market is characterized by the presence of several key players vying for market share and striving to differentiate themselves. The competitive dynamics within this market are influenced by factors such as product innovation, manufacturing capabilities, distribution networks, and strategic partnerships. The competitive landscape of the global oral thin films market features a mix of established pharmaceutical companies, specialized drug delivery technology providers, and emerging players. These companies continuously invest in research and development to develop innovative formulations and improve drug delivery capabilities. Manufacturing capabilities and capacity are also key factors in the competitive landscape. Companies with advanced manufacturing facilities and expertise gain a competitive advantage in terms of quality, scalability, and cost-efficiency. Strong manufacturing capabilities allow companies to meet the growing demand for oral thin films and ensure reliable supply to the market.

Oral Thin Films Market Top Player’s Company Profiles

  • IntelGenx Corp. (Canada)
  • Indivior PLC (UK)
  • Pfizer Inc. (USA)
  • Sumitomo Dainippon Pharma Co., Ltd. (Japan)
  • Novartis International AG (Switzerland)
  • Monosol Rx LLC (USA)
  • APR Applied Pharma Research SA (Switzerland)
  • LTS Lohmann Therapie-Systeme AG (Germany)
  • Pfizer CentreOne (USA)
  • NAL Pharma Co., Ltd. (South Korea)
  • Sun Pharmaceutical Industries Ltd. (India)
  • BioDelivery Sciences International, Inc. (USA)
  • ProSolus Pharmaceuticals (USA)
  • APRILIA S.R.L. (Italy)
  • Addex Pharma (France)
  • Medherant Limited (UK)
  • Mundipharma International Limited (UK)
  • GSK (GlaxoSmithKline) (UK)

Oral Thin Films Market Recent Developments

  • In October 2022, CURE Pharmaceutical Holding Corp. introduced Nutri-Strips, a revolutionary oral thin-film strip technology. Nutri-Strips are a convenient and effective way to deliver vitamins, minerals, and other nutrients.
  • In September 2022, LTS LOHMANN Therapie-Systeme AG acquired Tapemark Inc. Tapemark is a US-based CDMO specializing in transdermal drug delivery systems and oral thin film. This acquisition will allow LTS to expand its product portfolio and capabilities in the oral thin film market.
  • In September 2022, Aquestive Therapeutics announced that it entered into a license and supply agreement for Libervant (diazepam) Buccal Film with Pharmanovia, across the world. Libervant is a fast-dissolving buccal film formulation of diazepam that is used for the acute treatment of panic attacks.

Oral Thin Films Key Market Trends

  • Complex Manufacturing Processes: A significant restraint in the oral thin films market in 2022 was the complex manufacturing processes associated with these specialized dosage forms. Developing and scaling up the production of oral thin films require advanced equipment, expertise, and stringent quality control. The complexity of manufacturing and associated costs can limit the availability and affordability of oral thin films, hindering market growth.
  • Intellectual Property Concerns: Intellectual property concerns presented another restraint in the oral thin films market. Innovators and manufacturers in this sector face challenges related to patent protection, preventing potential imitation and infringement. Intellectual property concerns can impact market entry and the ability of companies to recoup investments in research and development, thereby affecting market growth and innovation.

Oral Thin Films Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our global oral thin films market analyses, North America is anticipated to hold a significant revenue share in the market, driven by factors such as a large patient pool, high healthcare expenditure, and the presence of major pharmaceutical companies. The region benefits from advanced healthcare infrastructure and a favorable regulatory environment, facilitating market growth. On the other hand, the Asia Pacific region is expected to witness rapid growth due to increasing awareness about oral thin films, rising healthcare expenditure, and a growing demand for convenient drug delivery systems. The market is characterized by various application areas, including pain management, hormone replacement therapy, anti-nausea, and psychiatric disorders, with pain management being a prominent segment. The market is propelled by factors such as the ease of administration, improved patient compliance, rapid onset of action, and advancements in oral thin film technologies.

However, challenges such as the high cost of development, stringent regulatory requirements, and competition from alternative drug delivery methods may impact market growth. Key trends in the market include the development of innovative formulations, partnerships and collaborations among pharmaceutical companies, and a focus on expanding product portfolios to cater to diverse therapeutic areas. Overall, the global oral thin films market offers opportunities for companies to capitalize on the increasing demand for convenient and patient-friendly drug delivery systems, emphasizing the need for continuous innovation and strategic partnerships.

What’s Included

NA

Report Metric Details
Market size value in 2022 USD 3.17 Billion
Market size value in 2031 USD 7.05 Billion
Growth Rate 9.3%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Sublingual Film, Fully Dissolving Dental/Buccal Film
  • Application
    • Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, and Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • IntelGenx Corp. (Canada)
  • Indivior PLC (UK)
  • Pfizer Inc. (USA)
  • Sumitomo Dainippon Pharma Co., Ltd. (Japan)
  • Novartis International AG (Switzerland)
  • Monosol Rx LLC (USA)
  • APR Applied Pharma Research SA (Switzerland)
  • LTS Lohmann Therapie-Systeme AG (Germany)
  • Pfizer CentreOne (USA)
  • NAL Pharma Co., Ltd. (South Korea)
  • Sun Pharmaceutical Industries Ltd. (India)
  • BioDelivery Sciences International, Inc. (USA)
  • ProSolus Pharmaceuticals (USA)
  • APRILIA S.R.L. (Italy)
  • Addex Pharma (France)
  • Medherant Limited (UK)
  • Mundipharma International Limited (UK)
  • GSK (GlaxoSmithKline) (UK)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Oral Thin Films Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Oral Thin Films Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Oral Thin Films Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Oral Thin Films Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Oral Thin Films Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Oral Thin Films Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Oral Thin Films Market size was valued at USD 3.17 Billion in 2022 and is poised to grow from USD 3.46 Billion in 2023 to USD 7.05 Billion by 2031, at a CAGR of 9.3% during the forecast period (2024-2031).

The global oral thin films market is characterized by the presence of several key players vying for market share and striving to differentiate themselves. The competitive dynamics within this market are influenced by factors such as product innovation, manufacturing capabilities, distribution networks, and strategic partnerships. The competitive landscape of the global oral thin films market features a mix of established pharmaceutical companies, specialized drug delivery technology providers, and emerging players. These companies continuously invest in research and development to develop innovative formulations and improve drug delivery capabilities. Manufacturing capabilities and capacity are also key factors in the competitive landscape. Companies with advanced manufacturing facilities and expertise gain a competitive advantage in terms of quality, scalability, and cost-efficiency. Strong manufacturing capabilities allow companies to meet the growing demand for oral thin films and ensure reliable supply to the market. 'ZIM Laboratories Limited (India)', 'IntelGenx Corp. (Canada)', 'Indivior PLC (UK)', 'Pfizer Inc. (USA)', 'Sumitomo Dainippon Pharma Co., Ltd. (Japan)', 'Novartis International AG (Switzerland)', 'Monosol Rx LLC (USA)', 'APR Applied Pharma Research SA (Switzerland)', 'LTS Lohmann Therapie-Systeme AG (Germany)', 'Pfizer CentreOne (USA)', 'Tesa Labtec GmbH (Germany)', 'NAL Pharma Co., Ltd. (South Korea)', 'Sun Pharmaceutical Industries Ltd. (India)', 'BioDelivery Sciences International, Inc. (USA)', 'ProSolus Pharmaceuticals (USA)', 'APRILIA S.R.L. (Italy)', 'Addex Pharma (France)', 'Medherant Limited (UK)', 'Mundipharma International Limited (UK)', 'GSK (GlaxoSmithKline) (UK)'

One of the key drivers in 2022 was the growing patient preference for non-invasive drug delivery methods. Oral thin films offer a convenient and patient-friendly alternative to traditional oral dosage forms like tablets and injections. Patients appreciate the ease of administration, rapid disintegration, and potentially improved medication compliance provided by oral thin films. This driver was further reinforced by the ongoing COVID-19 pandemic, where non-invasive drug delivery methods gained more prominence due to safety concerns.

Complex Manufacturing Processes: A significant restraint in the oral thin films market in 2022 was the complex manufacturing processes associated with these specialized dosage forms. Developing and scaling up the production of oral thin films require advanced equipment, expertise, and stringent quality control. The complexity of manufacturing and associated costs can limit the availability and affordability of oral thin films, hindering market growth.

North America emerges as the dominating region in the global oral thin films market. This region is characterized by advanced healthcare infrastructure, a strong pharmaceutical industry, and a high prevalence of various diseases requiring oral medication. The United States, in particular, contributes significantly to the market due to its robust healthcare system, increasing adoption of innovative drug delivery systems, and a large patient population. Moreover, North America is home to several key players in the oral thin films market, driving the dominance of this region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35H2121

$5,300
BUY NOW GET FREE SAMPLE